Efficacy and Safety of Single-dose Pegfilgrastim for CD34 + Cell Mobilization in Healthy Volunteers: A Phase 2 Study - Goto, Hideki; Sugita, Junichi; Hasegawa, Yuta; Hayasaka, Koji; Sunagoya, Kana; Hatase, Rie; Nishida, Mutsumi; Ichihashi, Yuki; Odera, Mitsuhiko; Senjo, Hajime; Yokoyama, Shota; Ara, Takahide; et al. (Transplantation, 2024)
Keywords: Antigens, CD34 - metabolism; Filgrastim - adverse effects; Granulocyte Colony-Stimulating Factor - adverse effects; Hematopoietic Stem Cell Mobilization; Humans; Polyethylene Glycols - adverse effects; Recombinant Proteins - adverse effects